Bromantane 99%

$35.00$120.00

Clear

Our Bromantane is sold in raw powder form packaged in a small easy access container.

Legal Disclaimer:

This product is sold as a pure compound for research purposes only and is not meant for use as a dietary supplement. Please refer to our terms and conditions prior to purchase.

Safety Information: Keep this product out of the reach of children. This material has limited research available about it and may result in adverse effects if improperly handled or consumed. This product is not a dietary supplement, but a pure substance, sold as a raw material. We attest exclusively to the quality, purity and description of the materials we provide. This product is for use and handling only by persons with the knowledge and equipment to safely handle this material. You agree to indemnify us for any adverse effects that may arise from improper handling and/or consumption of this product.

The articles and information on products that may be found on this website are provided exclusively for the purposes of providing information and education. Only in vitro testing should be done using the products that may be purchased from this website. Research that is carried out in vitro takes place outside of the human body. These items are not pharmaceuticals or medications, and the Food and Drug Administration has not given permission for the treatment or prevention of any disease, medical condition, or ailment using them.

m.

Need help on paying? No problem, we have compiled a quick tutorial for every available payment method

Continue to learn how to pay

Bromantane 99%

Bromantane
Bromantane.svg
Нашим русским друзьям
Chemical Nomenclature
Common names Bromantane, Bromantan, Ladasten
Substitutive name Bromantane
Systematic name N-(4-Bromophenyl)adamantan-2-amine
Class Membership
Psychoactive class Stimulant / Nootropic
Chemical class Adamantane

 

Bromantane (Ladasten) is a “actoprotector”: Actoprotectors improve body stability against physical stresses without raising oxygen consumption or heat. Actoprotectors are metabolic molecules with antihypoxic properties. They vary from antihypoxants by directly stimulating protein synthesis and working capability. Similar to stimulants, yet different: Actoprotectors are non-exhaustive. Actoprotectors boost not only cerebral (intellectual) but also physical work capacity, unlike nootropics.

LiteratureReichlin, S. (1969). Handbook of Experimental Pharmacology. The American Journal of The Medical Sciences (Vol. 258). https://doi.org/10.1097/00000441-196911000-00008Krapivin, S. V, Sergeeva, S. A., & Morozov, I. S. (1993). [A quantitative pharmaco-electroencephalographic analysis of the action of bromantane]. Biulleten’ Eksperimental’noi Biologii I Meditsiny, 116(11), 515–8. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8312546Burnat, P., Payen, A., Brumant-Payen, C. Le, Hugon, M., & Ceppa, F. (1997). Bromontan, a new doping agent. The Lancet, 350(9082), 963–964. https://doi.org/10.1016/S0140-6736(05)63310-7Viatleva, O. A., Barchukov, V. G., Morozov, I. S., Salenko, I. A., & Zhirnov, E. N. (2000). [The neuro- and psychophysiological effects of bromantane]. Voenno-Meditsinskii Zhurnal, 321(8), 61–5, 96. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/10998997Iezhitsa, I. N., Spasov, A. A., & Bugaeva, L. I. (2001). Effects of bromantan on offspring maturation and development of reflexes. Neurotoxicology and Teratology, 23(2), 213–222. https://doi.org/10.1016/S0892-0362(01)00119-2Iezhitsa, I. N., Spasov, A. A., Bugaeva, L. I., & Morozov, I. S. (2002). Toxic effect of single treatment with bromantane on neurological status of experimental animals. Bulletin of Experimental Biology and Medicine, 133(4), 380–383. https://doi.org/10.1023/A:1016206306875Oliynyk, S., & Oh, S. (2012). The pharmacology of actoprotectors: Practical application for improvement of mental and physical performance. Biomolecules and Therapeutics, 20(5), 446–456. https://doi.org/10.4062/biomolther.2012.20.5.446Morozov, I. S., Klimova, N. V, Karpova, T. D., & Shestopalov, S. S. (n.d.). [The characteristics of the neuropsychotropic activity of bromantane in laboratory animals]. Eksperimental’naia I Klinicheskaia Farmakologiia, 62(2), 3–6. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/10340117Kudrin, V. S., Sergeeva, S. A., Krasnykh, L. M., Miroshnichenko, I. I., Grekhova, T. V, & Gaĭnetdinov, R. R. (n.d.). [The effect of bromantane on the dopamin- and serotoninergic systems of the rat brain]. Eksperimental’naia I Klinicheskaia Farmakologiia, 58(4), 8–11. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/758076

References

  1.  Oliynyk, S., Oh, S. (September 2012). “The Pharmacology of Actoprotectors: Practical Application for Improvement of Mental and Physical Performance”Biomolecules & Therapeutics20 (5): 446–456. doi:10.4062/biomolther.2012.20.5.446ISSN 1976-9148.
  2.  Krapivin, S. V., Sergeeva, S. A., Morozov, I. S. (November 1993). “[A quantitative pharmaco-electroencephalographic analysis of the action of bromantane]”. Biulleten’ Eksperimental’noi Biologii I Meditsiny116 (11): 515–518. ISSN 0365-9615.
  3.  Burnat, P., Payen, A., Brumant-Payen, C. L., Hugon, M., Ceppa, F. (September 1997). “Bromontan, a new doping agent”The Lancet350 (9082): 963–964. doi:10.1016/S0140-6736(05)63310-7ISSN 0140-6736.
  4.  Viatleva, O. A., Barchukov, V. G., Morozov, I. S., Salenko, I. A., Zhirnov, E. N. (August 2000). “[The neuro- and psychophysiological effects of bromantane]”. Voenno-Meditsinskii Zhurnal321 (8): 61–65, 96. ISSN 0026-9050.
  5. ↑ Jump up to:5.0 5.1 Oliynyk, S., Oh, S.-K. (30 September 2012). “The Pharmacology of Actoprotectors: Practical Application for Improvement of Mental and Physical Performance”Biomolecules and Therapeutics20 (5): 446–456. doi:10.4062/biomolther.2012.20.5.446ISSN 1976-9148.
  6.  Kudrin, V. S., Sergeeva, S. A., Krasnykh, L. M., Miroshnichenko, I. I., Grekhova, T. V., Gaĭnetdinov, R. R. (August 1995). “[The effect of bromantane on the dopamin- and serotoninergic systems of the rat brain]”. Eksperimental’naia I Klinicheskaia Farmakologiia58 (4): 8–11. ISSN 0869-2092.
  7.  Morozov, I. S., Pukhova, G. S., Avdulov, N. A., Sergeeva, S. A., Spasov, A. A., Iezhitsa, I. N. (February 1999). “[The mechanisms of the neurotropic action of bromantan]”. Eksperimental’naia I Klinicheskaia Farmakologiia62 (1): 11–14. ISSN 0869-2092.
  8.  Iezhitsa, I. N., Spasov, A. A., Bugaeva, L. I., Morozov, I. S. (April 2002). “Toxic effect of single treatment with bromantane on neurological status of experimental animals”. Bulletin of Experimental Biology and Medicine133 (4): 380–383. doi:10.1023/a:1016206306875ISSN 0007-4888.
  9.  Morozov, I. S., Klimova, N. V., Karpova, T. D., Shestopalov, S. S. (April 1999). “[The characteristics of the neuropsychotropic activity of bromantane in laboratory animals]”. Eksperimental’naia I Klinicheskaia Farmakologiia62 (2): 3–6. ISSN 0869-2092.
  10.  Iëzhitsa IN, Bugaeva LI, Spasov AA, Morozov IS (2000). “[Effect of bromantane on the rat neurologic status in two month course]”Eksp Klin Farmakol (in Russian). 63 (5): 13–7. PMID 11109517.
  11.  Vakhitova, I. V., Iamidanov, R. S., Vakhitov, V. A., Seredenin, S. B. (April 2005). “[DNA macroarray analysis of gene expression changes in rat brain after single administration of 2-aminoadamantane compound]”. Molekuliarnaia Biologiia39 (2): 276–285. ISSN 0026-8984.
  12.  “Gesetz über den Verkehr mit Betäubungsmitteln (Betäubungsmittelgesetz – BtMG)” (in German). Bundesministerium der Justiz und für Verbraucherschutz. Retrieved December 28, 2019.
  13.  “Neue-psychoaktive-Stoffe-Gesetz (NpSG)” (in German). Bundesministerium der Justiz und für Verbraucherschutz. Retrieved December 28, 2019.
  14.  “§ 2 AMG” (in German). Bundesministerium der Justiz und für Verbraucherschutz. Retrieved December 28, 2019.
  15.  Prof. Dr. Helmut Pollähne (July 11, 2014). “Cannabinoide Kräutermischungen vor dem EuGH: Legal Highs bleiben legal” [Cannabinoid herbal mixtures at the ECJ: Legal highs stay legal] (in German). LTO. Retrieved December 28, 2019.
  16.  “Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien” (in German). Bundeskanzlei [Federal Chancellery of Switzerland]. Retrieved January 1, 2020.

Link to above reference

https://psychonautwiki.org/wiki/Bromantane

Additional information

Weight

10 Grams, 2 Grams, 5 Grams

Reviews

There are no reviews yet.

Be the first to review “Bromantane 99%”

Your email address will not be published.

×